The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Metampicilina     3,3-dimethyl-6-[[2- (methylideneamino)-2...

Synonyms: Metampicilline, AG-J-85829, SureCN1650135, BSPBio_003105, KBioGR_000634, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Elatocilline

 

Psychiatry related information on Elatocilline

  • The aim of our study was to compare probiotic bacterial strains such as Escherichia coli Nissle 1917 with nonprobiotic, pathogenic and nonpathogenic bacteria with respect to innate defense mechanisms in the intestinal mucosal cell [6].
  • Although the evidence is not conclusive and much further research is required, the data reviewed constitute a promising body of evidence supporting the protective role of milks fermented with probiotic cultures in colon cancer risk reduction [7].
  • The main parameters that have to be considered are the composition and processing of the cereal grains, the substrate formulation, the growth capability and productivity of the starter culture, the stability of the probiotic strain during storage, the organoleptic properties and the nutritional value of the final product [8].
 

High impact information on Elatocilline

 

Chemical compound and disease context of Elatocilline

 

Biological context of Elatocilline

 

Anatomical context of Elatocilline

  • RESULTS: Intragastric and s.c. administration of probiotic and E. coli DNA ameliorated the severity of DSS-induced colitis, whereas methylated probiotic DNA, calf thymus DNA, and DNase-treated probiotics had no effect [5].
  • Lactobacillus acidophilus is a probiotic organism that displays the ability to use prebiotic compounds such as fructooligosaccharides (FOS), which stimulate the growth of beneficial commensals in the gastrointestinal tract [22].
  • Among the large number of probiotic products in use today are bacterial spore formers, mostly of the genus Bacillus [23].
  • This protective effect was attributable to effects on the lamina propria mononuclear cell (LPMC) population, because it could be transferred by LPMC from probiotic-treated mice to naive mice [15].
  • Human studies have demonstrated that selected probiotic strains can influence the composition of the intestinal microflora and modulate the host immune system [24].
 

Associations of Elatocilline with other chemical compounds

 

Gene context of Elatocilline

 

Analytical, diagnostic and therapeutic context of Elatocilline

References

  1. A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Paton, A.W., Morona, R., Paton, J.C. Nat. Med. (2000) [Pubmed]
  2. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. Elmer, G.W., Surawicz, C.M., McFarland, L.V. JAMA (1996) [Pubmed]
  3. Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome. van Zanten, S.V. Gastroenterology (2005) [Pubmed]
  4. Prevention is the best defense: Probiotic prophylaxis of pouchitis. Katz, J.A. Gastroenterology (2003) [Pubmed]
  5. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Rachmilewitz, D., Katakura, K., Karmeli, F., Hayashi, T., Reinus, C., Rudensky, B., Akira, S., Takeda, K., Lee, J., Takabayashi, K., Raz, E. Gastroenterology (2004) [Pubmed]
  6. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Wehkamp, J., Harder, J., Wehkamp, K., Wehkamp-von Meissner, B., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Bengmark, S., Fellermann, K., Schröder, J.M., Stange, E.F. Infect. Immun. (2004) [Pubmed]
  7. Fermented milks, probiotic cultures, and colon cancer. Saikali, J., Picard, C., Freitas, M., Holt, P. Nutrition and cancer. (2004) [Pubmed]
  8. Application of cereals and cereal components in functional foods: a review. Charalampopoulos, D., Wang, R., Pandiella, S.S., Webb, C. Int. J. Food Microbiol. (2002) [Pubmed]
  9. Probiotics and commensals reverse TNF-alpha- and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Resta-Lenert, S., Barrett, K.E. Gastroenterology (2006) [Pubmed]
  10. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. O'Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O'Sullivan, G.C., Kiely, B., Collins, J.K., Shanahan, F., Quigley, E.M. Gastroenterology (2005) [Pubmed]
  11. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Jijon, H., Backer, J., Diaz, H., Yeung, H., Thiel, D., McKaigney, C., De Simone, C., Madsen, K. Gastroenterology (2004) [Pubmed]
  12. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Petrof, E.O., Kojima, K., Ropeleski, M.J., Musch, M.W., Tao, Y., De Simone, C., Chang, E.B. Gastroenterology (2004) [Pubmed]
  13. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Altermann, E., Russell, W.M., Azcarate-Peril, M.A., Barrangou, R., Buck, B.L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., Lick, S., Hamrick, A., Cano, R., Klaenhammer, T.R. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  14. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Adawi, D., Kasravi, F.B., Molin, G., Jeppsson, B. Hepatology (1997) [Pubmed]
  15. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. Di Giacinto, C., Marinaro, M., Sanchez, M., Strober, W., Boirivant, M. J. Immunol. (2005) [Pubmed]
  16. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Kruis, W., Fric, P., Pokrotnieks, J., Lukás, M., Fixa, B., Kascák, M., Kamm, M.A., Weismueller, J., Beglinger, C., Stolte, M., Wolff, C., Schulze, J. Gut (2004) [Pubmed]
  17. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. Taylor, A.L., Dunstan, J.A., Prescott, S.L. J. Allergy Clin. Immunol. (2007) [Pubmed]
  18. The genome sequence of the probiotic intestinal bacterium Lactobacillus johnsonii NCC 533. Pridmore, R.D., Berger, B., Desiere, F., Vilanova, D., Barretto, C., Pittet, A.C., Zwahlen, M.C., Rouvet, M., Altermann, E., Barrangou, R., Mollet, B., Mercenier, A., Klaenhammer, T., Arigoni, F., Schell, M.A. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  19. Genomic features of lactic acid bacteria effecting bioprocessing and health. Klaenhammer, T.R., Barrangou, R., Buck, B.L., Azcarate-Peril, M.A., Altermann, E. FEMS Microbiol. Rev. (2005) [Pubmed]
  20. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. Yan, F., Polk, D.B. J. Biol. Chem. (2002) [Pubmed]
  21. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Hart, A.L., Lammers, K., Brigidi, P., Vitali, B., Rizzello, F., Gionchetti, P., Campieri, M., Kamm, M.A., Knight, S.C., Stagg, A.J. Gut (2004) [Pubmed]
  22. Functional and comparative genomic analyses of an operon involved in fructooligosaccharide utilization by Lactobacillus acidophilus. Barrangou, R., Altermann, E., Hutkins, R., Cano, R., Klaenhammer, T.R. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  23. The use of bacterial spore formers as probiotics. Hong, H.A., Duc, l.e. .H., Cutting, S.M. FEMS Microbiol. Rev. (2005) [Pubmed]
  24. Food processing: probiotic microorganisms for beneficial foods. Schiffrin, E.J., Blum, S. Curr. Opin. Biotechnol. (2001) [Pubmed]
  25. Taxonomy and important features of probiotic microorganisms in food and nutrition. Holzapfel, W.H., Haberer, P., Geisen, R., Björkroth, J., Schillinger, U. Am. J. Clin. Nutr. (2001) [Pubmed]
  26. An in vitro study of the probiotic potential of a bile-salt-hydrolyzing Lactobacillus fermentum strain, and determination of its cholesterol-lowering properties. Pereira, D.I., McCartney, A.L., Gibson, G.R. Appl. Environ. Microbiol. (2003) [Pubmed]
  27. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Taylor, A.L., Hale, J., Wiltschut, J., Lehmann, H., Dunstan, J.A., Prescott, S.L. Clin. Exp. Allergy (2006) [Pubmed]
  28. Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. Ewaschuk, J.B., Walker, J.W., Diaz, H., Madsen, K.L. J. Nutr. (2006) [Pubmed]
  29. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. Sullivan, A., Barkholt, L., Nord, C.E. J. Antimicrob. Chemother. (2003) [Pubmed]
  30. The effect of a multispecies probiotic on the intestinal microbiota and bowel movements in healthy volunteers taking the antibiotic amoxycillin. Koning, C.J., Jonkers, D.M., Stobberingh, E.E., Mulder, L., Rombouts, F.M., Stockbrügger, R.W. Am. J. Gastroenterol. (2008) [Pubmed]
  31. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P.A., Moser, A.B., Desimone, C., Song, X.Y., Diehl, A.M. Hepatology (2003) [Pubmed]
  32. Saccharomyces boulardii inhibits ERK1/2 mitogen-activated protein kinase activation both in vitro and in vivo and protects against Clostridium difficile toxin A-induced enteritis. Chen, X., Kokkotou, E.G., Mustafa, N., Bhaskar, K.R., Sougioultzis, S., O'Brien, M., Pothoulakis, C., Kelly, C.P. J. Biol. Chem. (2006) [Pubmed]
  33. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D.C., Erckenbrecht, J., Raupach, B., Sonnenborn, U., Eckert, J., Schumann, R.R., Wiedenmann, B., Dignass, A.U., Sturm, A. Infect. Immun. (2006) [Pubmed]
  34. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Caballero-Franco, C., Keller, K., De Simone, C., Chadee, K. Am. J. Physiol. Gastrointest. Liver Physiol. (2007) [Pubmed]
  35. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., Campieri, M. Gastroenterology (2000) [Pubmed]
  36. Animal models: new cholesterol raising and lowering nutrients. Hassel, C.A. Curr. Opin. Lipidol. (1998) [Pubmed]
  37. Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Sheil, B., McCarthy, J., O'Mahony, L., Bennett, M.W., Ryan, P., Fitzgibbon, J.J., Kiely, B., Collins, J.K., Shanahan, F. Gut (2004) [Pubmed]
  38. Patho-biotechnology: using bad bugs to do good things. Sleator, R.D., Hill, C. Curr. Opin. Biotechnol. (2006) [Pubmed]
 
WikiGenes - Universities